CoMparison of TriflusAl and Clopidogrel Effect in Secondary Prevention of STroke Based on the CytochRome P450 2C19 GenOtyping (MAESTRO)
This study is ongoing, but not recruiting participants.
Gangnam Severance Hospital
Myung In Pharmaceutical Company, Ltd.
Information provided by (Responsible Party):
KyungYul Lee, Gangnam Severance Hospital
First received: August 3, 2010
Last updated: January 24, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||January 2015|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|